Red blood cells highly express type I platelet-activating factor-acetylhydrolase (PAF-AH) which consists of the alpha1/alpha2 complex. 2005

Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
Faculty of Pharmaceutical Sciences, Teikyo University, Sagamiko, Kanagawa 199-0195. karasawa@pharm.teikyo-u.ac.jp

Although red blood cells account for about 30% of total PAF-AH activity found in the blood, the physiological function of this enzyme is unknown. To understand the role and regulatory mechanism of this enzyme, we purified it from easily obtainable pig red blood cells. PAF-AH activity was mainly found in the soluble fraction of the red blood cells. Two peaks of enzyme activity appeared with increasing concentration of imidazole on column chromatography on nickel-nitroacetic acid (Ni-NTA) resin. We called these peaks of small and large enzyme activities fractions X and Y, respectively, and then further purified the enzymes by sequential chromatofocusing on Mono P and gel filtration on TSK G-3000. In the final preparation from fraction Y, two proteins bands corresponding to 26 kDa and 28 kDa were related to enzyme activity. Determination of the partial amino acid sequences of the proteins of 26 kDa and 28 kDa revealed that these proteins were identical to alpha(1) and alpha(2), respectively, both of which are catalytic subunits of Type I intracellular PAF-AH. On Western analysis, the 26 kDa and 28 kDa protein bands cross-reacted with specific monoclonal antibodies to alpha(1) and alpha(2), respectively. Since the apparent molecular weight of the natural enzyme was estimated to be about 60 kDa, the enzyme activity in fraction Y was thought to be that of a heterodimer consisting of alpha(1) and alpha(2). On the other hand, the enzyme activity in fraction X was thought to be that of a homodimer consisting of alpha(2). Other blood cells such as polymorphonuclear leukocytes and platelets only contained the alpha(2)/alpha(2) homodimer. It has been reported that the alpha(1)/alpha(2) heterodimer is poorly expressed in adult animals except for in the spermatogonium. Taken altogether, these results suggest that high expression of the alpha(1)/alpha(2) heterodimer is important for the physiological function of mature red blood cells.

UI MeSH Term Description Entries
D008970 Molecular Weight The sum of the weight of all the atoms in a molecule. Molecular Weights,Weight, Molecular,Weights, Molecular
D009504 Neutrophils Granular leukocytes having a nucleus with three to five lobes connected by slender threads of chromatin, and cytoplasm containing fine inconspicuous granules and stainable by neutral dyes. LE Cells,Leukocytes, Polymorphonuclear,Polymorphonuclear Leukocytes,Polymorphonuclear Neutrophils,Neutrophil Band Cells,Band Cell, Neutrophil,Cell, LE,LE Cell,Leukocyte, Polymorphonuclear,Neutrophil,Neutrophil Band Cell,Neutrophil, Polymorphonuclear,Polymorphonuclear Leukocyte,Polymorphonuclear Neutrophil
D001792 Blood Platelets Non-nucleated disk-shaped cells formed in the megakaryocyte and found in the blood of all mammals. They are mainly involved in blood coagulation. Platelets,Thrombocytes,Blood Platelet,Platelet,Platelet, Blood,Platelets, Blood,Thrombocyte
D004591 Electrophoresis, Polyacrylamide Gel Electrophoresis in which a polyacrylamide gel is used as the diffusion medium. Polyacrylamide Gel Electrophoresis,SDS-PAGE,Sodium Dodecyl Sulfate-PAGE,Gel Electrophoresis, Polyacrylamide,SDS PAGE,Sodium Dodecyl Sulfate PAGE,Sodium Dodecyl Sulfate-PAGEs
D004912 Erythrocytes Red blood cells. Mature erythrocytes are non-nucleated, biconcave disks containing HEMOGLOBIN whose function is to transport OXYGEN. Blood Cells, Red,Blood Corpuscles, Red,Red Blood Cells,Red Blood Corpuscles,Blood Cell, Red,Blood Corpuscle, Red,Erythrocyte,Red Blood Cell,Red Blood Corpuscle
D000595 Amino Acid Sequence The order of amino acids as they occur in a polypeptide chain. This is referred to as the primary structure of proteins. It is of fundamental importance in determining PROTEIN CONFORMATION. Protein Structure, Primary,Amino Acid Sequences,Sequence, Amino Acid,Sequences, Amino Acid,Primary Protein Structure,Primary Protein Structures,Protein Structures, Primary,Structure, Primary Protein,Structures, Primary Protein
D000818 Animals Unicellular or multicellular, heterotrophic organisms, that have sensation and the power of voluntary movement. Under the older five kingdom paradigm, Animalia was one of the kingdoms. Under the modern three domain model, Animalia represents one of the many groups in the domain EUKARYOTA. Animal,Metazoa,Animalia
D013552 Swine Any of various animals that constitute the family Suidae and comprise stout-bodied, short-legged omnivorous mammals with thick skin, usually covered with coarse bristles, a rather long mobile snout, and small tail. Included are the genera Babyrousa, Phacochoerus (wart hogs), and Sus, the latter containing the domestic pig (see SUS SCROFA). Phacochoerus,Pigs,Suidae,Warthogs,Wart Hogs,Hog, Wart,Hogs, Wart,Wart Hog
D015153 Blotting, Western Identification of proteins or peptides that have been electrophoretically separated by blot transferring from the electrophoresis gel to strips of nitrocellulose paper, followed by labeling with antibody probes. Immunoblotting, Western,Western Blotting,Western Immunoblotting,Blot, Western,Immunoblot, Western,Western Blot,Western Immunoblot,Blots, Western,Blottings, Western,Immunoblots, Western,Immunoblottings, Western,Western Blots,Western Blottings,Western Immunoblots,Western Immunoblottings
D043203 1-Alkyl-2-acetylglycerophosphocholine Esterase A lipoprotein-associated PHOSPHOLIPASE A2 which modulates the action of PLATELET ACTIVATING FACTOR by hydrolyzing the SN-2 ester bond to yield the biologically inactive lyso-platelet-activating factor. It has specificity for phospholipid substrates with short-chain residues at the SN-2 position, but inactive against long-chain phospholipids. Deficiency in this enzyme is associated with many diseases including ASTHMA, and HYPERCHOLESTEROLEMIA. PAF Acetylhydrolase,Platelet-Activating Factor Hydrolase,Lipoprotein-Associated Phospholipase A(2),Lipoprotein-Associated Phospholipase A2,Lp-PLA(2),Lp-PLA2,PAF 2-Acetylhydrolase,PAF 2-Acylhydrolase,PAF Acetylhydrolase II,Platelet-activating Factor Acetylhydrolase IB,1 Alkyl 2 acetylglycerophosphocholine Esterase,2-Acetylhydrolase, PAF,Acetylhydrolase II, PAF,Acetylhydrolase, PAF,Esterase, 1-Alkyl-2-acetylglycerophosphocholine,Factor Hydrolase, Platelet-Activating,Hydrolase, Platelet-Activating Factor,Lipoprotein Associated Phospholipase A2,Lp PLA2,PAF 2 Acetylhydrolase,PAF 2 Acylhydrolase,Phospholipase A2, Lipoprotein-Associated,Platelet Activating Factor Hydrolase,Platelet activating Factor Acetylhydrolase IB

Related Publications

Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
May 2002, Journal of biochemistry,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
March 2003, Progress in lipid research,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
September 1994, The International journal of biochemistry,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
May 2008, Animal reproduction science,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
February 2007, Arquivos brasileiros de cardiologia,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
February 2009, Cardiovascular drugs and therapy,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
November 2008, Brain and nerve = Shinkei kenkyu no shinpo,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
April 2008, The New England journal of medicine,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
April 2008, The New England journal of medicine,
Ken Karasawa, and Mariko Shirakura, and Ayako Harada, and Noriko Satoh, and Kazuaki Yokoyama, and Morio Setaka, and Keizo Inoue
April 2008, The New England journal of medicine,
Copied contents to your clipboard!